| Sandoz Pharmaceuticals AG - Tofacitinib Sandoz 10 mg, Filmtabletten | | 69483 | | 02 | | Tofacitinib Sandoz 10 mg | | Filmtabletten | | | | | | 19.02.2025 | | |
| | Composition | | tofacitinibum 10 mg ut tofacitinibi citras, cellulosum microcristallinum, lactosum monohydricum, carmellosum natricum conexum corresp. natrium 1.08 mg, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum, macrogolum 3350, triacetinum, E 132, E 133, pro compresso obducto corresp. lactosum monohydricum 125.12 mg. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Tofacitinibum | 10 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 133 | | color. | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 56 | DDP | DDP | B | | Non |
|
|
